Skip to main content
Ryan Wilcox, MD, Oncology, Ann Arbor, MI, University of Michigan Medical Center

RyanAWilcoxMDPhD

Oncology Ann Arbor, MI

Cutaneous Lymphoma, Hematologic Oncology

Assistant Professor

Dr. Wilcox is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Wilcox's full profile

Already have an account?

Education & Training

  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2007 - 2011
  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2004 - 2007
  • Mayo Clinic College of Medicine
    Mayo Clinic College of MedicineClass of 2004

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 2011 - 2024
  • ID State Medical License
    ID State Medical License 2018 - 2023
  • MN State Medical License
    MN State Medical License 2005 - 2011
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • A Phase 2 Study of the Dual SYK/JAK Inhibitor Cerdulatinib Demonstrates Good Tolerability and Clinical Response in Relapsed/Refractory Peripheral T-Cell Lymphoma and C...
    Ryan A. Wilcox, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Characteristics, Treatment Patterns, and Outcomes in Primary Cutaneous Gamma Delta T Cell Lymphoma (PCGDTCL): A Real World Multi-Institutional Analysis of a Rare Malig...
    Ryan A. Wilcox, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Ruxolitinib Is Active and Well Tolerated in Adult Patients with Secondary Hemophagocytic Lymphohistiocytosis: Preliminary Results of an Ongoing, Open-Label, Single Cen... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Hospital Affiliations